134 related articles for article (PubMed ID: 35032826)
1. Dendritic cell immunotherapy with miR-155 enriched tumor-derived exosome suppressed cancer growth and induced antitumor immune responses in murine model of colorectal cancer induced by CT26 cell line.
Asadirad A; Baghaei K; Hashemi SM; Dehnavi S; Ghanbarian H; Mortaz E; Anissian A; Asadzadeh Aghdaei H; Amani D
Int Immunopharmacol; 2022 Mar; 104():108493. PubMed ID: 35032826
[TBL] [Abstract][Full Text] [Related]
2. The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer.
Hosseini M; Baghaei K; Hajivalili M; Zali MR; Ebtekar M; Amani D
Life Sci; 2022 Feb; 290():120234. PubMed ID: 34953890
[TBL] [Abstract][Full Text] [Related]
3. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
[TBL] [Abstract][Full Text] [Related]
5. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells.
Li J; Lin W; Huang T; Chen M; Lin Q
Exp Cell Res; 2024 Jun; 439(1):114073. PubMed ID: 38704079
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.
Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M
Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857
[TBL] [Abstract][Full Text] [Related]
8. miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy.
Zhang M; Shi Y; Zhang Y; Wang Y; Alotaibi F; Qiu L; Wang H; Peng S; Liu Y; Li Q; Gao D; Wang Z; Yuan K; Dou FF; Koropatnick J; Xiong J; Min W
Cancer Immunol Immunother; 2020 Jun; 69(6):951-967. PubMed ID: 32076794
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Antitumor Efficacy of Cancer Stem Cell-Derived DRibble Vaccine on Colorectal Carcinoma.
Fu C; Tian G; Duan J; Liu K; Zhang C; Yan W; Wang Y
Int J Med Sci; 2021; 18(14):3249-3260. PubMed ID: 34400894
[TBL] [Abstract][Full Text] [Related]
10. Exosomes derived from Rab27a‑overexpressing tumor cells elicit efficient induction of antitumor immunity.
Li W; Mu D; Tian F; Hu Y; Jiang T; Han Y; Chen J; Han G; Li X
Mol Med Rep; 2013 Dec; 8(6):1876-82. PubMed ID: 24146068
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
[TBL] [Abstract][Full Text] [Related]
12. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.
Wu YG; Wu GZ; Wang L; Zhang YY; Li Z; Li DC
Med Oncol; 2010 Sep; 27(3):736-42. PubMed ID: 19669608
[TBL] [Abstract][Full Text] [Related]
14. Effective strategy of dendritic cell-based immunotherapy for advanced tumor-bearing hosts: the critical role of Th1-dominant immunity.
Mashino K; Sadanaga N; Tanaka F; Ohta M; Yamaguchi H; Mori M
Mol Cancer Ther; 2002 Aug; 1(10):785-94. PubMed ID: 12492111
[TBL] [Abstract][Full Text] [Related]
15. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
[TBL] [Abstract][Full Text] [Related]
16. Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor.
Wang C; Huang X; Wu Y; Wang J; Li F; Guo G
Int J Biol Sci; 2020; 16(4):633-643. PubMed ID: 32025211
[TBL] [Abstract][Full Text] [Related]
17. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
[TBL] [Abstract][Full Text] [Related]
18. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.
Tsang YW; Huang CC; Yang KL; Chi MS; Chiang HC; Wang YS; Andocs G; Szasz A; Li WT; Chi KH
BMC Cancer; 2015 Oct; 15():708. PubMed ID: 26472466
[TBL] [Abstract][Full Text] [Related]
19. Improved Antitumor Efficacy of Combined Vaccine Based on the Induced HUVECs and DC-CT26 Against Colorectal Carcinoma.
Zhang Q; Xie C; Wang D; Yang Y; Liu H; Liu K; Zhao J; Chen X; Zhang X; Yang W; Li X; Tian F; Dong Z; Lu J
Cells; 2019 May; 8(5):. PubMed ID: 31121964
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
Huang F; Wan J; Hu W; Hao S
Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
